Patents by Inventor Fidel P. Zavala

Fidel P. Zavala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Malaria immunogen and methods for using same
    Patent number: 12121574
    Abstract: An immunogen useful for treating malaria generally includes an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide that includes the peptide NANPNVDPNANPNVD (SEQ ID NO:2) linked to the immunogenic carrier. The immunogen may be administered to a subject having or at risk of having malaria. Alternatively, the immunogen may be administered to an individual having or at risk of having Plasmodium falciparum blood stage parasitemia. In some cases, the immunogen can be administered in combination with another therapeutic agent for treating malaria of Plasmodium falciparum blood stage parasitemia.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: October 22, 2024
    Assignees: UNM RAINFOREST INNOVATIONS, THE JOHNS HOPKINS UNIVERSITY, VAXINE PTY LTD.
    Inventors: Bryce C. Chackerian, Fidel P. Zavala, David S. Peabody, Nikolai Petrovsky, Lucie Jelinkova
  • MALARIA IMMUNOGEN AND METHODS FOR USING SAME
    Publication number: 20230102159
    Abstract: An immunogen useful for treating malaria generally includes an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide that includes the peptide NANPNVDPNANPNVD (SEQ ID NO:2) linked to the immunogenic carrier. The immunogen may be administered to a subject having or at risk of having malaria. Alternatively, the immunogen may be administered to an individual having or at risk of having Plasmodium falciparum blood stage parasitemia. In some cases, the immunogen can be administered in combination with another therapeutic agent for treating malaria of Plasmodium falciparum blood stage parasitemia.
    Type: Application
    Filed: September 27, 2022
    Publication date: March 30, 2023
    Inventors: Bryce C. Chackerian, Fidel P. Zavala, David S. Peabody, Nikolai Petrovsky, Lucia Jelinkova
  • Recombinant Adenovirus Vaccines
    Publication number: 20140294890
    Abstract: Recombinant adenovirus vaccines comprising recombinant adenoviruses whose hexon, fiber or protein IX capsid proteins are engineered to include exogenous peptide segments, e.g. vaccines for human papillomavirus (HPV) and malaria.
    Type: Application
    Filed: July 19, 2013
    Publication date: October 2, 2014
    Applicant: The Johns Hopkins University
    Inventors: Gary W. Ketner, Richard B.S. Roden, Fidel P. Zavala
  • Recombinant Adenovirus Vaccines
    Publication number: 20100272753
    Abstract: Recombinant adenovirus vaccines comprising recombinant adenoviruses whose hexon, fiber or protein IX capsid proteins are engineered to include exogenous peptide segments, e.g. vaccines for human papillomavirus (HPV) and malaria.
    Type: Application
    Filed: October 26, 2007
    Publication date: October 28, 2010
    Applicant: The Johns Hopkins University
    Inventors: Gary W. Ketner, Richard B. Roden, Fidel P. Zavala